OGEN vs OKE · rev $37.7K vs P/E 15, rev $21.70B
Oragenics Inc (OGEN) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
OGEN currently screens at market cap $2.7M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the OGEN and OKE stock pages for the full models.
Not investment advice.